⌘K

Login Start Free

Home/Filings/4/0000950170-24-028611

4//SEC Filing

Suri Anish 4

Accession 0000950170-24-028611

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 4:00 PM ET

Size

5.3 KB

Accession

0000950170-24-028611

Insider Transaction Report

Form 4

Period: 2024-03-06

Cue Biopharma, Inc.CUE

Chief Scientific Officer

Transactions

Award
Stock Option (right to buy)
2024-03-06+300,000→ 300,000 total
Exercise: $1.94Exp: 2034-03-05→ Common Stock (300,000 underlying)

Footnotes (1)

[F1]This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0001739130

Filing Metadata

Form type: 4
Filed: Mar 7, 7:00 PM ET
Accepted: Mar 8, 4:00 PM ET
Size: 5.3 KB

View on SEC.gov